Global Radiopharmaceutical Packaging Market Strategic Research Report

Scope of the Report

The global Radiopharmaceutical Packaging market size is predicted to grow from US$ 234 million in 2025 to US$ 351 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

Radiopharmaceutical packaging refers to a special packaging system designed specifically for radiopharmaceuticals. It must meet strict radiation protection standards and usually adopts an inner and outer double-layer structure: the inner packaging is used to directly contain radiopharmaceuticals to ensure sealing and radiation shielding; the outer packaging is additionally labeled with protective labels and information such as the drug name, activity, half-life, etc. to meet the safety requirements of transportation, storage and clinical use.

The radiopharmaceutical packaging industry holds promising growth prospects, driven primarily by the expanding demand for nuclear medicine diagnostics and therapy, the widespread adoption of PET/SPECT imaging, the rapid development of targeted radionuclide therapies for cancer, and the acceleration of global radiopharmaceutical R&D and commercialization. Given the unique characteristics of radiopharmaceuticals—such as continuous ionizing radiation emission, short half-lives for certain products, and stringent transport timing requirements—packaging systems must meet rigorous standards for radiation shielding, leak-proof sealing, impact resistance, temperature control, contamination prevention, traceability, and compliance with hazardous materials transport regulations. Consequently, there will be sustained demand for shielding containers (vials, transport canisters, and shielded boxes) and specialized secondary packaging made from lead, tungsten, and other high-density shielding materials. As the application of therapeutic radiopharmaceuticals like Lu-177 and Ac-225 expands, and as production shifts from a few large centers to regional manufacturing and distribution networks, the frequency of shipments and the demand for specialized packaging are expected to rise steadily. Meanwhile, the industry is evolving toward lightweight shielding materials, modular packaging, smart temperature and radiation monitoring, RFID/GPS tracking, and reusable packaging, alongside stricter compliance with UN, IAEA, and national regulations for the transport of hazardous goods. Overall, radiopharmaceutical packaging represents a specialized market segment characterized by high barriers to entry—including technical, regulatory, and customer certification hurdles—and offers long-term, stable growth potential amidst the global expansion of nuclear medicine, particularly in the radioligand therapy sector.

This report presents a comprehensive overview of the global Radiopharmaceutical Packaging market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Type A Packaging
• Type B Packaging
• Type C Packaging

Segment by Shielding Thickness

• Low Shielding Thickness（<10 mm Pb Equivalent）
• Medium Shielding Thickness（10–25 mm Pb Equivalent）
• High Shielding Thickness（25–50 mm Pb Equivalent）
• Ultra-high Shielding Thickness（>50 mm Pb Equivalent）

Segment by Shielding Materials

• Lead-Shielded Packaging
• Tungsten-Shielded Packaging
• Lead-Tungsten Composite Shielded Packaging
• Polyethylene/Polymer-Shielded Packaging
• Others

Segment by players, this report covers

• Von Gahlen
• Eckert & Ziegler Medical
• Vulcan GMS
• ACILA Dr. Weidner GmbH
• Comecer
• Grantek
• Medi-Radiopharma
• Lemer Pax
• Eichrom Technologies Inc
• Frontier Technology Corporation
• Stevcon Packaging and Logistics
• ANSTO
• Mirion
• Huayi Isotopes
• TopRun Cold Chain Solution

Segment by Application

• Diagnostic Radiopharmaceuticals (PET Imaging Agents, SPECT Imaging Agents, Myocardial Imaging Agents, Bone Imaging Agents, etc.)
• Therapeutic Radiopharmaceuticals (Radioligand Drugs, Thyroid Therapeutic Agents, Tumor-Targeted Radiopharmaceuticals, etc.)
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Radiopharmaceutical Packaging market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Diagnostic Radiopharmaceuticals (PET Imaging Agents, SPECT Imaging Agents, Myocardial Imaging Agents, Bone Imaging Agents, etc.), Therapeutic Radiopharmaceuticals (Radioligand Drugs, Thyroid Therapeutic Agents, Tumor-Targeted Radiopharmaceuticals, etc.), Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact